Bio2Skin Bio2Skin, the first clinically skin-preserving biomaterial replacing silicones/acrylate as medical skin adhesives
- Coordinator
- Besthealth4u Lda, Portugal
- Runs
- 1 November 2024 to 31 October 2026
- Status
- Running
- EU funding
- €2.5m
- Total cost
- —
- Partners
- 1 organisations in 1 countries
- Type
- European Innovation Council
- Grant agreement
- 101188638
What the project is doing
In the project's own words, from its summary on CORDIS.
External medical devices, such as ostomy pouches, wound dressings or wearable electronic devices, require the use of medical adhesives for their attachment to the skin. However, prolonged use of current medical adhesives is associated with serious adverse skin reactions, MARSI (Medical Adhesives-Related Skin Injuries). This underreported issue is prevalent in 25% of wound care cases and is associated with enormous health care and economic burdens.
BH4U aims to address this challenge with Bio2Skin. A patented revolutionary glueless medical adhesive that uses the natural features of the skin to establish a water-based link and overcomes the disadvantages of acrylic/silicone adhesives. Bio2Skin is a bio-based, cost-effective, recyclable solution offering gentle, safe adhesion and kind removal. The product, with a potential of >250M EUR by 2030, will be sold under license to medical adhesive manufacturers and external medical devices manufacturers.
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Besthealth4u Lda | Braga | Portugal | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI